NRP104

· New River Pharmaceuticals

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for NRP104, covering 2007-11-05 to 2011-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD [Phase 3]